Mikhail I. Kalinin
Oncologist-doctor
Oncology
Dixion
Russian Federation
Biography
Doctor of the highest qualification category, an honors pupil of the Russian Federation. In 1992 he graduated with honors from the Voronezh State Medical University with a degree in Medicine. From 1992 to 1993 he passed internship on the specialty "surgery" on the basis of the Medsan unit of the Orel Steel Plant. From 1993 to 1995 he worked as an oncologist in the polyclinic of the MSCH OSPZ. From 1995 to the present time he works as a thoracic oncologist-surgeon in the fourth oncology department of the BUD OOD (Orlovsky Oncological Dispensary). In 2007 he became a laureate of the regional level of the Federal project "Professional team of the country" in the category "Healthcare". Since 2008, he is a member of the Council of the Federation of Independent Trade Unions of the Oryol region, and since 2009 - a member of the board of the TFOMS Orel region. In 2010 he underwent further training in the specialty "oncology" at the Moscow Institute of Oncology.P.A. Herzen Rosmedtechnology. In 2012, he studied at the Center for High Medical Technologies "Johnson and Johnson" in Kazan, specialty "Manual skills in endoscopic surgery." In February 2013, he underwent further training at the St. Petersburg State University of Higher Professional Education. IPPavlova of the Ministry of Health of Russia (St. Petersburg State Medical University) on the topic "Laser technology in oncology with the course of photodynamic therapy." The certificate is valid until May 17, 2018. Systematically participates in the work of domestic and international conferences and congresses, dedicated to the current problems of oncology and onco surgery. Performs a wide range of operations on the organs of the thorax; with oncopathology of the lungs, esophagus, breast, mediastinum, cardinal part of the stomach. The sphere of direct professional interests in recent years is the introduction of minimally invasive surgical methods, including thoracoscopic techniques and laser technologies, in the treatment of patients with malignant neoplasms.
Research Interest
oncology